Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
Is a |
ephedrinhydrochlorid |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ephedrine hydrochloride (substance) |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
Is a |
Product containing guaifenesin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Guaifenesin |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Smooth muscle relaxant (substance) |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator (substance) |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
Has manufactured dose form |
Conventional release oral syrup (dose form) |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
middel med virkning på det muskuloskeletale system |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
Is a |
Product containing ephedrine and guaifenesin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
Is a |
Product containing ephedrine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|